Effect of antiresorptive drugs on osseointegrated dental implants
A systematic review published in the Journal of Clinical Medicine aimed to evaluate the effect of antiresorptive drugs on osseointegrated dental implants.
Of the dental implants evaluated in the study, 23% failed after antiresorptive treatment, the majority of which were attributed to medication-related osteonecrosis of the jaw that developed after medication. Following treatment, 27% of the implants could be preserved, with three-fourths of sites affected by medication-related osteonecrosis completely healed and the remaining sites stable.
"Regular monitoring and maintaining good periodontal health, particularly within the first three years of antiresorptive drug therapy initiation, are crucial for implant success," according to the study.
Read more: PracticeUpdate
The article presented here is intended to inform you about the broader media perspective on dentistry, regardless of its alignment with the ADA's stance. It is important to note that publication of an article does not imply the ADA's endorsement, agreement, or promotion of its content.